Brought to you by WBIW News and Network Indiana
Last updated on Thursday, May 26, 2016
(INDIANAPOLIS) - Eli Lilly has an ambitious seven year plan, a giant beer merger just got a little closer to reality.
Eli Lilly laid out an ambitious agenda for launching up to 20 new drugs by 2023.
During an investor presentation, the company also said it hopes to add a significant number of uses for its existing therapies in order to bolster those drugs' market strength.
Lilly said that it would be focusing on key franchises such as diabetes, oncology, and neurodegenerative diseases like Alzheimer's.
1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at comments@wbiw.com
© Ad-Venture Media, Inc. All Rights Reserved.